Cargando…

A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals

A key aspect of the systematic review process is study evaluation to understand the strengths and weaknesses of individual studies included in the review. The present manuscript describes the process currently being used by the Environmental Protection Agency’s (EPA) Integrated Risk Information Syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Dishaw, Laura, Yost, Erin, Arzuaga, Xabier, Luke, April, Kraft, Andrew, Walker, Teneille, Thayer, Kris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422842/
https://www.ncbi.nlm.nih.gov/pubmed/32434117
http://dx.doi.org/10.1016/j.envint.2020.105736
_version_ 1783749356522831872
author Dishaw, Laura
Yost, Erin
Arzuaga, Xabier
Luke, April
Kraft, Andrew
Walker, Teneille
Thayer, Kris
author_facet Dishaw, Laura
Yost, Erin
Arzuaga, Xabier
Luke, April
Kraft, Andrew
Walker, Teneille
Thayer, Kris
author_sort Dishaw, Laura
collection PubMed
description A key aspect of the systematic review process is study evaluation to understand the strengths and weaknesses of individual studies included in the review. The present manuscript describes the process currently being used by the Environmental Protection Agency’s (EPA) Integrated Risk Information System (IRIS) Program to evaluate animal toxicity studies, illustrated by application to the recent systematic reviews of two phthalates: diisobutyl phthalate (DIBP) and diethyl phthalate (DEP). The IRIS Program uses a domain-based approach that was developed after careful consideration of tools used by others to evaluate experimental animal studies in toxicology and pre-clinical research. Standard practice is to have studies evaluated by at least two independent reviewers for aspects related to reporting quality, risk of bias/internal validity (e.g., randomization, blinding at outcome assessment, methods used to expose animals and assess outcomes, etc.), and sensitivity to identify factors that may limit the ability of a study to detect a true effect. To promote consistency across raters, prompting considerations and example responses are provided to reviewers, and a pilot phase is conducted. The evaluation process is performed separately for each outcome reported in a study, as the utility of a study may vary for different outcomes. Input from subject matter experts is used to identify chemical- and outcome-specific considerations (e.g., lifestage of exposure and outcome assessment when considering reproductive effects) to guide judgments within particular evaluation domains. For each evaluation domain, reviewers reach a consensus on a rating of Good, Adequate, Deficient, or Critically Deficient. These individual domain ratings are then used to determine the overall confidence in the study (High Confidence, Medium Confidence, Low Confidence, or Deficient). Study evaluation results, including the justifications for reviewer judgements, are documented and made publicly available in EPA’s version of Health Assessment Workspace Collaborative (HAWC), a free and open source web-based software application. (The views expressed are those of the authors and do not necessarily represent the views or policies of the US EPA).
format Online
Article
Text
id pubmed-8422842
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-84228422021-09-07 A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals Dishaw, Laura Yost, Erin Arzuaga, Xabier Luke, April Kraft, Andrew Walker, Teneille Thayer, Kris Environ Int Article A key aspect of the systematic review process is study evaluation to understand the strengths and weaknesses of individual studies included in the review. The present manuscript describes the process currently being used by the Environmental Protection Agency’s (EPA) Integrated Risk Information System (IRIS) Program to evaluate animal toxicity studies, illustrated by application to the recent systematic reviews of two phthalates: diisobutyl phthalate (DIBP) and diethyl phthalate (DEP). The IRIS Program uses a domain-based approach that was developed after careful consideration of tools used by others to evaluate experimental animal studies in toxicology and pre-clinical research. Standard practice is to have studies evaluated by at least two independent reviewers for aspects related to reporting quality, risk of bias/internal validity (e.g., randomization, blinding at outcome assessment, methods used to expose animals and assess outcomes, etc.), and sensitivity to identify factors that may limit the ability of a study to detect a true effect. To promote consistency across raters, prompting considerations and example responses are provided to reviewers, and a pilot phase is conducted. The evaluation process is performed separately for each outcome reported in a study, as the utility of a study may vary for different outcomes. Input from subject matter experts is used to identify chemical- and outcome-specific considerations (e.g., lifestage of exposure and outcome assessment when considering reproductive effects) to guide judgments within particular evaluation domains. For each evaluation domain, reviewers reach a consensus on a rating of Good, Adequate, Deficient, or Critically Deficient. These individual domain ratings are then used to determine the overall confidence in the study (High Confidence, Medium Confidence, Low Confidence, or Deficient). Study evaluation results, including the justifications for reviewer judgements, are documented and made publicly available in EPA’s version of Health Assessment Workspace Collaborative (HAWC), a free and open source web-based software application. (The views expressed are those of the authors and do not necessarily represent the views or policies of the US EPA). 2020-05-17 2020-08 /pmc/articles/PMC8422842/ /pubmed/32434117 http://dx.doi.org/10.1016/j.envint.2020.105736 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Dishaw, Laura
Yost, Erin
Arzuaga, Xabier
Luke, April
Kraft, Andrew
Walker, Teneille
Thayer, Kris
A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals
title A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals
title_full A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals
title_fullStr A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals
title_full_unstemmed A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals
title_short A novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals
title_sort novel study evaluation strategy in the systematic review of animal toxicology studies for human health assessments of environmental chemicals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422842/
https://www.ncbi.nlm.nih.gov/pubmed/32434117
http://dx.doi.org/10.1016/j.envint.2020.105736
work_keys_str_mv AT dishawlaura anovelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT yosterin anovelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT arzuagaxabier anovelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT lukeapril anovelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT kraftandrew anovelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT walkerteneille anovelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT thayerkris anovelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT dishawlaura novelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT yosterin novelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT arzuagaxabier novelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT lukeapril novelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT kraftandrew novelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT walkerteneille novelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals
AT thayerkris novelstudyevaluationstrategyinthesystematicreviewofanimaltoxicologystudiesforhumanhealthassessmentsofenvironmentalchemicals